Cargando…
Network analytics for drug repurposing in COVID-19
To better understand the potential of drug repurposing in COVID-19, we analyzed control strategies over essential host factors for SARS-CoV-2 infection. We constructed comprehensive directed protein–protein interaction (PPI) networks integrating the top-ranked host factors, the drug target proteins...
Autores principales: | Siminea, Nicoleta, Popescu, Victor, Sanchez Martin, Jose Angel, Florea, Daniela, Gavril, Georgiana, Gheorghe, Ana-Maria, Iţcuş, Corina, Kanhaiya, Krishna, Pacioglu, Octavian, Popa, Laura Ioana, Trandafir, Romica, Tusa, Maria Iris, Sidoroff, Manuela, Păun, Mihaela, Czeizler, Eugen, Păun, Andrei, Petre, Ion |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690228/ https://www.ncbi.nlm.nih.gov/pubmed/34864885 http://dx.doi.org/10.1093/bib/bbab490 |
Ejemplares similares
-
Validation of transcriptome signature reversion for drug repurposing in oncology
por: Koudijs, Karel K M, et al.
Publicado: (2022) -
Vir2Drug: a drug repurposing framework based on protein similarities between pathogens
por: Minadakis, George, et al.
Publicado: (2022) -
Network controllability solutions for computational drug repurposing using genetic algorithms
por: Popescu, Victor-Bogdan, et al.
Publicado: (2022) -
BindingSite-AugmentedDTA: enabling a next-generation pipeline for interpretable prediction models in drug repurposing
por: Yousefi, Niloofar, et al.
Publicado: (2023) -
Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19
por: Tomazou, Marios, et al.
Publicado: (2021)